Literature DB >> 17250724

CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course.

D Galimberti1, D Scalabrini, C Fenoglio, C Comi, M De Riz, E Venturelli, C Lovati, C Mariani, F Monaco, N Bresolin, E Scarpini.   

Abstract

CXCL10 (interferon-gamma-inducible protein-10) levels are increased in cerebrospinal fluid of multiple sclerosis (MS) patients with symptomatic attacks of inflammatory demyelination, supporting a role for this molecule in MS pathogenesis. Two hundred and twenty-six patients with MS and 235 controls were genotyped for G --> C and T --> C single nucleotide polymorphisms (SNPs) in exon 4 of CXCL10 gene. Haplotypes were tested for association and correlated with clinical variables. The two SNPs studied were in complete linkage disequilibrium. None of the determined haplotypes was associated with MS. However, carriers of the GGTT haplotype (defined as wild type, according to the sequence in National Centre for Biotechnology Information (NCBI) database) had a significantly lower progression index than non-carriers (P = 0.016). Furthermore, amongst patients who had an initial relapsing remitting (RR) course of the disease, the time between onset and second episode was significantly longer in GGTT carriers (P = 0.021). Considering secondary progressive (SP)-MS patients, the time between the initial RR form and the subsequent worsening to SP was longer in this group (P = 0.08). Therefore, the GGTT haplotype of the CXCL10 gene is not a susceptibility factor for the development of MS, but is probably to influence the course of MS, possibly contributing to slow down the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250724     DOI: 10.1111/j.1468-1331.2006.01629.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

Review 1.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

2.  CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis.

Authors:  Daniel Kotrych; Violetta Dziedziejko; Krzysztof Safranow; Marek Drozdzik; Andrzej Pawlik
Journal:  Rheumatol Int       Date:  2015-02-22       Impact factor: 2.631

Review 3.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

4.  Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations.

Authors:  Enzo Spisni; Donata Luiselli; Marco Sazzini; Sara De Fanti; Anna Cherubini; Andrea Quagliariello; Giuseppe Profiti; Pier Luigi Martelli; Rita Casadio; Chiara Ricci; Massimo Campieri; Alberto Lanzini; Umberto Volta; Giacomo Caio; Claudio Franceschi
Journal:  Genes Nutr       Date:  2016-05-23       Impact factor: 5.523

Review 5.  The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?

Authors:  Jens Geginat; Moira Paroni; Massimiliano Pagani; Daniela Galimberti; Raffaele De Francesco; Elio Scarpini; Sergio Abrignani
Journal:  Trends Immunol       Date:  2017-05-23       Impact factor: 16.687

6.  Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Authors:  Jagannadha R Avasarala; Sridar V Chittur; Ajish D George; John A Tine
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

7.  Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer.

Authors:  Jan Dimberg; Marita Skarstedt; Sture Löfgren; Niklas Zar; Andreas Matussek
Journal:  Biomed Rep       Date:  2014-03-17

8.  CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria.

Authors:  Nana Wilson; Adel Driss; Wesley Solomon; Carmen Dickinson-Copeland; Hassana Salifu; Vidhan Jain; Neeru Singh; Jonathan Stiles
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.